Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1634 1682
This examiner grants 53% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18434556 | NOVEL IMMUNOPROBE-BASED METHOD TO ASSESS ORGAN INJURY STATUS THROUGH A BIOFLUID-BASED CELL-FREE DNA (CFDNA) ASSAY | Final Rejection | The Regents of the University of California |
| 17783263 | TARGETED PHAGE THERAPY | Non-Final OA | The Regents of the University of California |
| 18120714 | METHODS FOR DETECTING AND TREATING PROGESTERONE-RESISTANT INFERTILITY | Final Rejection | The Feinstein Institutes for Medical Research |
| 17576503 | ASSAYING OVARIAN CYST FLUID | Final Rejection | The Johns Hopkins University |
| 18037309 | COMPREHENSIVE GENOMIC PROFILING (CGP) OF METASTATIC INVASIVE LOBULAR CARCINOMAS REVEALS HETEROGENEITY | Non-Final OA | Foundation Medicine, Inc. |
| 17822332 | TARGETED MEASURE OF TRANSCRIPTIONAL ACTIVITY RELATED TO HORMONE RECEPTORS | Final Rejection | Yale University |
| 18557660 | METHOD FOR PREDICTING PROGNOSIS OF GASTRIC CANCER | Non-Final OA | INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY |
| 18158732 | GENE FUSIONS AND GENE VARIANTS ASSOCIATED WITH CANCER | Non-Final OA | Life Technologies Corporation |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy